The thought of using medical marijuana to treat pain can be daunting, not least, says Releaf founder Franco Brockelman, because the lack of data makes it difficult to fully understand what strains and doses will work for your particular symptoms.
It is this lack that drove Brockelman to launch Releaf in June. It’s an app that helps medical marijuana patients track their experiences with the drug throughout the “high” it gives them and collects that data for future reference. We profiled Releaf and Brockelman back in August.
At the time, Releaf only specifically supported the experience of smoking. But many medical users eat edibles or apply tinctures and topicals, so now Releaf has expanded to support that as well.
— releaf (@releafapp) November 22, 2016
“Since our initial launch in June, users have been clamoring for support for these methods, and our team has been working very hard to make this update,” Brockelman said in a statement. “Our vision has always been to support and help as many people as we possibly can, and we feel this is a huge step towards that goal.”
Simply enter information about the symptom you’re trying to treat, the strain and dose of cannabis you’re ingesting (and how you’re ingesting or using it) and then respond to prompts about how you feel over the course of your “session.”
“Dosing is already hard enough with edibles,” Brockelman said. “Releaf takes care of the math so you always know how much you’re taking. And after your session, you can easily refer back to the app to know what size dose worked well for you in the past. We really believe that with better information you can have better experiences.”
Brockelman and his team primarily work for a software consulting company based in Takoma — Releaf is a project originally inspired by the needs of Brockelman’s mother. The app is free to download and use, as the ethos of the project is about helping people and gathering data. Eventually, as Brockelman told Technical.ly in August, he sees partnerships with clinics or product tracking capabilities as a way toward monetization.-30-
CAVA launched a redesigned app this week as digital orders continue to grow
Gaithersburg’s Novavax moves into phase 3 of its of COVID-19 vaccine trial
It’s now possible to pay for a Metro ride with your iPhone
Too much, too early: The quest for a vaccine for COVID-19 has been doomed from the beginning
Sign-up for daily news updates from Technical.ly Dc